 |
28 Diseases |  |
11 Trials |
|
11 Trials |  |
282 News |  |
| «123456» |
- |||| Pegasys (pegylated interferon α -2a) / Roche
Trial completion: A Study of Peginterferon Alfa-2a [PEGASYS] in Patients With Chronic Hepatitis B Who Are HBeAg Positive (clinicaltrials.gov) - Mar 30, 2014
P4, N=265, Completed, Sponsor: Hoffmann-La Roche
Active, not recruiting --> Completed
- |||| Pegasys (pegylated interferon α -2a) / Roche
Trial completion, Combination therapy: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B (clinicaltrials.gov) - Mar 30, 2014
P4, N=281, Completed, Sponsor: Hoffmann-La Roche
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||||| adefovir dipivoxil / Generic mfg.
Trial completion: Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B (clinicaltrials.gov) - Feb 22, 2014
P3, N=173, Completed, Sponsor: Gilead Sciences
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV (clinicaltrials.gov) - Feb 22, 2014
P2, N=90, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed No longer recruiting --> Completed
- ||||||| entecavir / Generic mfg., adefovir dipivoxil / Generic mfg.
Trial completion: Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection (clinicaltrials.gov) - Feb 22, 2014
P3, N=69, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed Active, not recruiting --> Completed
- | adefovir dipivoxil / Generic mfg.
Trial completion: The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients (clinicaltrials.gov) - Feb 19, 2014
P3, N=505, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Combination therapy: Adefovir and Lamivudine for Entecavir Resistance (ALTER Study) (clinicaltrials.gov) - Feb 13, 2014
P4, N=20, Completed, Sponsor: Korea University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Tyzeka (telbivudine) / Novartis
Enrollment closed: Antiviral Efficacy of Switching to ETV Plus TDF (clinicaltrials.gov) - Jan 29, 2014
P4, N=104, Active, not recruiting, Sponsor: Yonsei University
Active, not recruiting --> Completed Not yet recruiting --> Active, not recruiting
- entecavir / Generic mfg., lamivudine / Generic mfg., adefovir dipivoxil / Generic mfg.
Trial initiation date: Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral Therapy (clinicaltrials.gov) - Jan 7, 2014
P4, N=310, Recruiting, Sponsor: Seng Gee Lim
Not yet recruiting --> Active, not recruiting Initiation date: Sep 2013 --> Jan 2014
- entecavir / Generic mfg., lamivudine / Generic mfg., adefovir dipivoxil / Generic mfg.
Enrollment open: Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral Therapy (clinicaltrials.gov) - Jan 7, 2014
P4, N=310, Recruiting, Sponsor: Seng Gee Lim
Initiation date: Sep 2013 --> Jan 2014 Not yet recruiting --> Recruiting
- ||||||| adefovir dipivoxil / Generic mfg.
Trial completion, Observational data: Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV. (clinicaltrials.gov) - Jan 5, 2014
P3b, N=107, Completed, Sponsor: Gilead Sciences
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- entecavir / Generic mfg., adefovir dipivoxil / Generic mfg.
Enrollment closed, Combination therapy, Monotherapy: Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy (clinicaltrials.gov) - Oct 27, 2013
P4, N=360, Active, not recruiting, Sponsor: Nanfang Hospital of Southern Medical University
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- lamivudine / Generic mfg.
Trial completion: EXPLORE: Efficacy Optimizing Research of Lamivudine Therapy (clinicaltrials.gov) - Oct 27, 2013
P4, N=366, Completed, Sponsor: Nanfang Hospital of Southern Medical University
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- || adefovir dipivoxil / Generic mfg.
Trial completion: Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B (clinicaltrials.gov) - Oct 13, 2013
P3, N=48, Completed, Sponsor: Gilead Sciences
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | entecavir / Generic mfg., lamivudine / Generic mfg., adefovir dipivoxil / Generic mfg.
New P4 trial: Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral Therapy (clinicaltrials.gov) - Aug 22, 2013
P4, N=310, Recruiting, Sponsor: Seng Gee Lim
- entecavir / Generic mfg., adefovir dipivoxil / Generic mfg.
Enrollment closed, Monotherapy: IN-US-0205: Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis B (clinicaltrials.gov) - Jul 13, 2013
P4, N=102, Active, not recruiting, Sponsor: Asan Medical Center
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ||||||| entecavir / Generic mfg., adefovir dipivoxil / Generic mfg.
Trial completion: Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation (clinicaltrials.gov) - Jun 16, 2013
P3, N=195, Completed, Sponsor: Bristol-Myers Squibb
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- lamivudine HBV / Generic mfg., lamivudine / Generic mfg., adefovir dipivoxil / Generic mfg.
Trial completion, Monotherapy: Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis B (clinicaltrials.gov) - May 7, 2013
P4, N=40, Completed, Sponsor: Thomas Jefferson University
Active, not recruiting --> Completed Recruiting --> Completed
- ||||||| entecavir / Generic mfg., lamivudine / Generic mfg., adefovir dipivoxil / Generic mfg.
Trial completion, Combination therapy, Monotherapy: DEFINE: Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus (clinicaltrials.gov) - Apr 22, 2013
P3, N=629, Completed, Sponsor: Bristol-Myers Squibb
Recruiting --> Completed Active, not recruiting --> Completed
- entecavir / Generic mfg., adefovir dipivoxil / Generic mfg.
Enrollment open: 3E Extension Study (clinicaltrials.gov) - Apr 16, 2013
P4, N=600, Recruiting, Sponsor: Nanfang Hospital of Southern Medical University
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Roferon A (recombinant interferon alfa-2a) / Roche
Enrollment change: DNA-EVAL: Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a (clinicaltrials.gov) - Apr 15, 2013
P=N/A, N=19, Completed, Sponsor: University Hospital, Limoges
Not yet recruiting --> Recruiting N=25 --> 19
- | Roferon A (recombinant interferon alfa-2a) / Roche
Trial completion: DNA-EVAL: Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a (clinicaltrials.gov) - Apr 15, 2013
P=N/A, N=19, Completed, Sponsor: University Hospital, Limoges
N=25 --> 19 Active, not recruiting --> Completed
- | entecavir / Generic mfg., adefovir dipivoxil / Generic mfg.
New P4 trial: 3E Extension Study (clinicaltrials.gov) - Apr 13, 2013
P4, N=600, Recruiting, Sponsor: Nanfang Hospital of Southern Medical University
- | entecavir / Generic mfg.
New P4 trial: Dragon-Ex: Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy (clinicaltrials.gov) - Apr 9, 2013
P4, N=360, Recruiting, Sponsor: Nanfang Hospital of Southern Medical University
- | Tyzeka (telbivudine) / Novartis
New P4 trial: TeSLA: Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot Study (clinicaltrials.gov) - Mar 3, 2013
P4, N=60, Recruiting, Sponsor: Korea University
- ||||| Tyzeka (telbivudine) / Novartis
New P4 trial: Telbivudine Renoprotective Effect in Patients With the HBV-related Liver Cirrhosis: a Randomized Controlled Trial (clinicaltrials.gov) - Feb 24, 2013
P4, N=300, Active, not recruiting, Sponsor: Lin Bingliang
- ||| entecavir / Generic mfg., adefovir dipivoxil / Generic mfg.
Enrollment change: Suboptimal Responders to Adefovir Switching to Entecavir (clinicaltrials.gov) - Jan 3, 2013
P4, N=228, Completed, Sponsor: Bristol-Myers Squibb
Active, not recruiting --> Completed N=169 --> 228
- | lamivudine HBV / Generic mfg., adefovir dipivoxil / Generic mfg.
New P4 trial: TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA (clinicaltrials.gov) - Nov 20, 2012
P4, N=171, Enrolling by invitation, Sponsor: Keimyung University Dongsan Medical Center
- adefovir dipivoxil / Generic mfg.
Trial withdrawal: Effect of Age on the Renal Clearance of Adefovir (clinicaltrials.gov) - Nov 19, 2012
P4, N=0, Withdrawn, Sponsor: University of California, San Francisco
N=169 --> 228 Completed --> Withdrawn
- adefovir dipivoxil / Generic mfg.
Enrollment change: Effect of Age on the Renal Clearance of Adefovir (clinicaltrials.gov) - Nov 19, 2012
P4, N=0, Withdrawn, Sponsor: University of California, San Francisco
Completed --> Withdrawn N=16 --> 0
- lamivudine HBV / Generic mfg., lamivudine / Generic mfg., adefovir dipivoxil / Generic mfg.
Trial initiation date: Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients (clinicaltrials.gov) - Nov 1, 2012
P4, N=160, Recruiting, Sponsor: Taipei Veterans General Hospital, Taiwan
N=16 --> 0 Initiation date: Dec 2011 --> Sep 2012
- lamivudine HBV / Generic mfg., lamivudine / Generic mfg., adefovir dipivoxil / Generic mfg.
Enrollment open: Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients (clinicaltrials.gov) - Nov 1, 2012
P4, N=160, Recruiting, Sponsor: Taipei Veterans General Hospital, Taiwan
Initiation date: Dec 2011 --> Sep 2012 Not yet recruiting --> Recruiting
- |||| Trial completion: Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B (clinicaltrials.gov) - Oct 17, 2012
P4, N=219, Completed, Sponsor: Korea University
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Trial completion: CAESAR: Entecavir Plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Patients Who Fail Lamivudine Plus Adefovir (clinicaltrials.gov) - Sep 25, 2012
P4, N=90, Completed, Sponsor: Asan Medical Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Tyzeka (telbivudine) / Novartis
New P4 trial: Telbivudine Renoprotective Effect in Patients With HBV-related Liver Cirrhosis (clinicaltrials.gov) - Sep 24, 2012
P4, N=120, Active, not recruiting, Sponsor: Shao-quan Zhang
- | Levovir (clevudine) / Bukwang Pharma, Eisai
Trial completion: A Clinical Trial to Investigate the Pharmacokinetic Drug-drug Interaction of Clevudine and Adefovir Dipivoxil After Oral Administration in Healthy Male Subjects (clinicaltrials.gov) - Sep 15, 2012
P1, N=42, Completed, Sponsor: Bukwang Pharmaceutical
Active, not recruiting --> Completed Recruiting --> Completed
- | adefovir dipivoxil / Generic mfg.
Trial completion: Phase I Study to Investigate the Safety and Efficacy of HBV DNA Vaccine (clinicaltrials.gov) - Aug 2, 2012
P1, N=27, Completed, Sponsor: Genexine, Inc.
Recruiting --> Completed Recruiting --> Completed
- ||| Levovir (clevudine) / Bukwang Pharma, Eisai
Enrollment closed, Monotherapy: A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B (clinicaltrials.gov) - Jul 23, 2012
P4, N=200, Active, not recruiting, Sponsor: Bukwang Pharmaceutical
Recruiting --> Completed Recruiting --> Active, not recruiting
- ||||| Levovir (clevudine) / Bukwang Pharma, Eisai
Enrollment closed: A Pilot Study to Evaluate the Safety and Efficacy of Clevudine or Adefovir Patients With LC-B (clinicaltrials.gov) - Jul 23, 2012
P3, N=102, Active, not recruiting, Sponsor: Bukwang Pharmaceutical
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | entecavir / Generic mfg., adefovir dipivoxil / Generic mfg.
New P4 trial, Monotherapy: IN-US-0205: Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis B (clinicaltrials.gov) - Jul 10, 2012
P4, N=102, Active, not recruiting, Sponsor: Asan Medical Center
- |||| Pegasys (pegylated interferon ? -2a) / Roche, Roferon A (recombinant interferon alfa-2a) / Roche
Enrollment open: PAS: PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients (clinicaltrials.gov) - Jun 6, 2012
P4, N=90, Recruiting, Sponsor: Foundation for Liver Research
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- ||||| entecavir / Generic mfg., lamivudine / Generic mfg., adefovir dipivoxil / Generic mfg.
Enrollment change, Combination therapy, Monotherapy: DEFINE: Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus (clinicaltrials.gov) - May 31, 2012
P3, N=629, Completed, Sponsor: Bristol-Myers Squibb
Not yet recruiting --> Recruiting N=420 --> 629
- | Tyzeka (telbivudine) / Novartis
New P4 trial: Antiviral Efficacy of Switching to ETV Plus TDF (clinicaltrials.gov) - May 13, 2012
P4, N=104, Active, not recruiting, Sponsor: Yonsei University
- || entecavir / Generic mfg., adefovir dipivoxil / Generic mfg.
Enrollment closed: ADVPR: Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders (clinicaltrials.gov) - May 7, 2012
P=N/A, N=120, Active, not recruiting, Sponsor: Pacific Health Foundation
N=420 --> 629 Recruiting --> Active, not recruiting
- || Tyzeka (telbivudine) / Novartis
Clinical: EBEREST: Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine (clinicaltrials.gov) - May 6, 2012
P3, N=30, Completed, Sponsor: Novartis Pharmaceuticals
Recruiting --> Active, not recruiting Recruiting --> Completed
- adefovir dipivoxil / Generic mfg.
Enrollment change: Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) (clinicaltrials.gov) - May 2, 2012
P2, N=0, Withdrawn, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed N=110 --> 0
- Tyzeka (telbivudine) / Novartis
Trial withdrawal: Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B (clinicaltrials.gov) - Apr 30, 2012
P4, N=0, Withdrawn, Sponsor: Novartis
N=110 --> 0 Terminated --> Withdrawn
- Tyzeka (telbivudine) / Novartis
Enrollment change: Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B (clinicaltrials.gov) - Apr 30, 2012
P4, N=0, Withdrawn, Sponsor: Novartis
Terminated --> Withdrawn N=184 --> 0
- | Levovir (clevudine) / Bukwang Pharma, Eisai
Enrollment change: A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function (clinicaltrials.gov) - Apr 23, 2012
P4, N=43, Completed, Sponsor: Bukwang Pharmaceutical
N=184 --> 0 N=72 --> 43
- | Levovir (clevudine) / Bukwang Pharma, Eisai
Trial completion: A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function (clinicaltrials.gov) - Apr 23, 2012
P4, N=43, Completed, Sponsor: Bukwang Pharmaceutical
N=72 --> 43 Recruiting --> Completed